1.
International Agency for Research on Cancer. 2008.
2.
WHO. Human papillomavirus infection and cervical cancer WHO; 2010 [cited 2010 February
21].
3.
Anorlu RI. Cervical cancer: the sub-Saharan African perspective. Reproductive health
matters. 2008;16(32):41-9.
4.
Mutyaba T, Mirembe F, Sandin S, Weiderpass E. Male partner involvement in reducing
loss to follow-up after cervical cancer screening in Uganda. International Journal
of Gynecology & Obstetrics. 2009;107(2):103-6.
5.
WHO. Prevention of cervical cancer through screening using Visual inspection with
acetic acid (VIA) and treatment with cryotherapy. A demonstration project in six African
countries: Malawi, Madagascar, Nigeria, Uganda, The United republic of Tanzania and
Zambia. . Geneva, Switzerland: World Health Organization. : African Population and
Health Research Center, International Agency for Research on Cancer 2012.
6.
Parkin DM, Nambooze S, Wabwire‐Mangen F, Wabinga HR. Changing cancer incidence in
Kampala, Uganda, 1991–2006. International Journal of Cancer. 2010;126(5):1187-95.
7.
Parkin DM, Almonte M, Bruni L, Clifford G, Curado M-P, Pineros M. Burden and trends
of type-specific human papillomavirus infections and related diseases in the Latin
America and Caribbean region. Vaccine. 2008;26:L1-L15.
8.
Banura C, Sandin S, van Doorn L-J, Quint W, Kleter B, Wabwire-Mangen F, et al. Research
article Type-specific incidence, clearance and predictors of cervical human papillomavirus
infections (HPV) among young women: a prospective study in Uganda. 2010.
9.
PATH. Protecting girls and women from cervical cancer. 2008.
10.
Boyce T, Holmes A. Addressing health inequalities in the delivery of the human papillomavirus
vaccination programme: examining the role of the school nurse. PLoS One. 2012;7(9):e43416.
11.
WHO. Human papillomavirus vaccines, WHO position paper. Wkly Epidemiol Rec. 2009;
84: 118–131. WHO, 2009.
12.
Grace JA. Adolescent immunization: Challenges and opportunities. The Journal of school
nursing. 2006;22(2):87-93.
13.
Kharbanda EO, Kahn JA. Vaccinating teens: current guidelines, challenges, and opportunities.
Pediatric annals. 2010;39(8):483-9.
14.
MOH. uptake of HPV vaccine per district in Uganda. Ministry of Health Uganda2016.
15.
Raffle AE. Challenges of implementing human papillomavirus (HPV) vaccination policy.
BMJ: British Medical Journal. 2007;335(7616):375-7.
16.
Turner AG. Sampling frames and master samples. United Nations Secretariat Statistics
Division. 2003.
17.
Strauss A, Corbin J. Grounded theory methodology. Handbook of qualitative research.
1994;17:273-85.
18.
Kiberu VM, Matovu JK, Makumbi F, Kyozira C, Mukooyo E, Wanyenze RK. Strengthening
district-based health reporting through the district health management information
software system: the Ugandan experience. BMC Medical Informatics and Decision Making.
2014;14(1):40.
19.
Garrib A, Herbst K, Dlamini L, McKenzie A, Stoops N, Govender T, et al. An evaluation
of the district health information system in rural South Africa. SAMJ: South African
Medical Journal. 2008;98(7):549-52.
20.
La Torre G, De Vito E, Ficarra MG, Firenze A, Gregorio P, Boccia A. Is there a lack
of information on HPV vaccination given by health professionals to young women? Vaccine.
2013;31(42):4710-3.
21.
Kessels SJ, Marshall HS, Watson M, Braunack-Mayer AJ, Reuzel R, Tooher RL. Factors
associated with HPV vaccine uptake in teenage girls: a systematic review. Vaccine.
2012;30(24):3546-56.
22.
Helen Marshall, Philip Ryan, Don Roberton, Baghurst P. A cross-sectional survey to
assess community attitudes to introduction of Human Papillomavirus vaccine. Australian
and New Zealand Journal of public health. 2007.
23.
Mullins TL, Griffioen AM, Glynn S, Zimet GD, Rosenthal SL, Fortenberry JD, et al.
Human papillomavirus vaccine communication: perspectives of 11-12 year-old girls,
mothers, and clinicians. Vaccine. 2013;31(42):4894-901.
24.
Ferrer HB, Trotter C, Hickman M, Audrey S. Barriers and facilitators to HPV vaccination
of young women in high-income countries: a qualitative systematic review and evidence
synthesis. BMC public health. 2014;14:700.
25.
Cassidy B, Schlenk EA. Uptake of the human papillomavirus vaccine: a review of the
literature and report of a quality assurance project. Journal of Pediatric Health
Care. 2012;26(2):92-101.
26.
Kester LM, Shedd-Steele RB, Dotson-Roberts CA, Smith J, Zimet GD. The effects of a
brief educational intervention on human papillomavirus knowledge and intention to
initiate HPV vaccination in 18-26 year old young adults. Gynecol Oncol. 2014;132 Suppl
1:S9-12.
27.
Dorell CG, Yankey D, Santibanez TA, Markowitz LE. Human papillomavirus vaccination
series initiation and completion, 2008-2009. Pediatrics. 2011;128(5):830-9.
28.
Vermandere H, van Stam MA, Naanyu V, Michielsen K, Degomme O, Oort F. Uptake of the
human papillomavirus vaccine in Kenya: testing the health belief model through pathway
modeling on cohort data. Globalization and Health. 2016;12.
29.
Bastani R, Glenn BA, Tsui J, Chang LC, Marchand EJ, Taylor VM, et al. Understanding
suboptimal human papillomavirus vaccine uptake among ethnic minority girls. Cancer
epidemiology, biomarkers & prevention : a publication of the American Association
for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2011;20(7):1463-72.
30.
Jo Waller LAVMaJW. Mothers' Attitudes towards Preventing Cervical Cancer through Human
Papillomavirus Vaccination: A Qualitative Study. 2006.
31.
Ports KA, Reddy DM, Rameshbabu A. Barriers and Facilitators to HPV Vaccination: Perspectives
from Malawian Women. Women & health. 2013;53(6):630-45.
32.
Wigle J, Coast E, Watson-Jones D. Human papillomavirus (HPV) vaccine implementation
in low and middle-income countries (LMICs): Health system experiences and prospects().
Vaccine. 2013;31(37):3811-7.
33.
Hongoro C, McPake B. How to bridge the gap in human resources for health. The Lancet.
2004;364(9443):1451-6.
34.
Kakuma R, Minas H, van Ginneken N, Dal Poz MR, Desiraju K, Morris JE, et al. Human
resources for mental health care: current situation and strategies for action. The
Lancet. 2011;378(9803):1654-63.
35.
Zaffran M, Vandelaer J, Kristensen D, Melgaard B, Yadav P, Antwi-Agyei KO, et al.
The imperative for stronger vaccine supply and logistics systems. Vaccine. 2013;31:B73-B80.
37.
Ladner J, Besson MH, Audureau E, Rodrigues M, Saba J. Experiences and lessons learned
from 29 HPV vaccination programs implemented in 19 low and middle-income countries,
2009-2014. BMC Health Serv Res. 2016;16.
38.
Wigle J, Coast E, Watson-Jones D. Human papillomavirus (HPV) vaccine implementation
in low and middle-income countries (LMICs): health system experiences and prospects.
Vaccine. 2013;31(37):3811-7.
39.
Lee H, Kim M, Kiang P, Shi L, Tan K, Chea P, et al. Factors Associated with HPV Vaccination
among Cambodian American Teenagers. Public health nursing (Boston, Mass). 2016;33(6):493-501.
40.
Brewer NT, Fazekas KI. Predictors of HPV vaccine acceptability: a theory-informed,
systematic review. Prev Med. 2007;45(2-3):107-14.
41.
GAVI. GAVI factsheet Uganda. 2017.
42.
Gerend MA, Zapata C, Reyes E. Predictors of human papillomavirus vaccination among
daughters of low-income Latina mothers: the role of acculturation. J Adolesc Health.
2013;53(5):623-9.